Key facts
- This page summarizes John G. Morikis's Form 4 filing for JOHNSON & JOHNSON (JNJ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Dec 2025, 16:15.
John G. Morikis - 26 Nov 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)
- Reporting relationship
- Director
- Issuer ticker
- JNJ
- Reported as of
- 26 Nov 2025
- Net transaction value
- +$257,688
- SEC form
- 4
- Accepted by SEC
- 01 Dec 2025, 16:15:39 UTC
- Prior SEC filing
- 25 Nov 2025
- Next SEC filing
- 24 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joleen Morgan, as attorney-in-fact for John Morikis
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John G. Morikis filed Form 4 for JOHNSON & JOHNSON (JNJ) on 01 Dec 2025.
Change
- Previous filing in this sequence was filed on 25 Nov 2025.
- Current net transaction value: +$257,688.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001203523
Primary reporting owner
MORIKIS JOHN G
- Relationship
- Director
- Address
- ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK
- Signature
- /s/ Joleen Morgan, as attorney-in-fact for John Morikis
- Signature date
- 01 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JNJ
transaction
Common Stock
Purchase
- Transaction value
- $257,688
- Shares
- +1,250
- Change %
- +209%
- Price
- $206.15
- Shares after
- 1,849
- Date
- 26 Nov 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.